Prophylaxis of heterotopic ossification-an updated review

被引:121
|
作者
Baird E.O. [2 ]
Kang Q.K. [1 ,2 ]
机构
[1] Clemson University, Department of Bioengineering, Clemson, SC
[2] Medical University of South Carolina, Department of Orthopaedic Surgery, Charleston, SC
关键词
Indomethacin; Bone Morphogenetic Protein; Heterotopic Ossification; Acetabular Fracture; Diffuse Idiopathic Skeletal Hyperostosis;
D O I
10.1186/1749-799X-4-12
中图分类号
学科分类号
摘要
Heterotopic ossification (HO) is defined as the process by which trabecular bone forms outside of the skeletal structure, occupying space in soft tissue where it does not normally exist. The current popular prophylactic treatment modalities include non-steroidal anti-inflammatory drugs (NSAIDs) and radiation therapy, although the literature remains inconclusive as to which is superior. Additionally, both treatments can lead to adverse effects to the patient. Recently there have been several studies attempting to identify new aspects of the etiology of heterotopic bone formation and introduce new prophylactic modalities with increased efficacy and fewer side effects. For this review, we selectively retrieved articles from Medline published from 1958-2008 on the prophylaxis of HO with the aim of assisting readers in quickly grasping the current status of research and clinical aspects of HO prophylaxis.
引用
收藏
相关论文
共 50 条
  • [1] Heterotopic Ossification in Hip Arthroscopy: an Updated Review
    Adrian Z. Kurz
    Eugenie LeRoux
    Michael Riediger
    Ryan Coughlin
    Nicole Simunovic
    Andrew Duong
    Jovan R. Laskovski
    Olufemi R. Ayeni
    Current Reviews in Musculoskeletal Medicine, 2019, 12 : 147 - 155
  • [2] Heterotopic Ossification in Hip Arthroscopy: an Updated Review
    Kurz, Adrian Z.
    LeRoux, Eugenie
    Riediger, Michael
    Coughlin, Ryan
    Simunovic, Nicole
    Duong, Andrew
    Laskovski, Jovan R.
    Ayeni, Olufemi R.
    CURRENT REVIEWS IN MUSCULOSKELETAL MEDICINE, 2019, 12 (02) : 147 - 155
  • [3] Omitted prophylaxis of heterotopic ossification
    Schwarze, M.
    Merle, C.
    Glanzmann, P.
    Schiltenwolf, M.
    ORTHOPADE, 2020, 49 (09): : 815 - 817
  • [4] RADIATION PROPHYLAXIS OF HETEROTOPIC OSSIFICATION
    PELLEGRINI, VD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (03): : 743 - 744
  • [5] Radiation prophylaxis for heterotopic ossification of the knee
    Chidel, MA
    Suh, JH
    Matejczyk, MB
    JOURNAL OF ARTHROPLASTY, 2001, 16 (01): : 1 - 6
  • [6] RADIATION PROPHYLAXIS OF HETEROTOPIC OSSIFICATION - RESPONSE
    SEEGENSCHMIEDT, MH
    MARTUS, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (03): : 693 - 694
  • [7] Biomaterials in heterotopic ossification: Prophylaxis and promotion
    Lou, Xu
    Huang, Dan
    Li, Guangfeng
    Bai, Long
    Su, Jiacan
    Yue, Hua
    CHEMICAL ENGINEERING JOURNAL, 2024, 497
  • [8] Unterlassene OssifikationsprophylaxeOmitted prophylaxis of heterotopic ossification
    M. Schwarze
    C. Merle
    P. Glanzmann
    M. Schiltenwolf
    Der Orthopäde, 2020, 49 : 815 - 817
  • [9] Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review
    Haffer, Henryk
    Mueller, Michael
    Ascherl, Rudolf
    Perka, Carsten
    Winkler, Tobias
    HIP INTERNATIONAL, 2022, 32 (02) : 144 - 151
  • [10] Prophylaxis of Heterotopic Ossification of the Hip: Systematic Review and Meta-Analysis
    Vavken, Patrick
    Castellani, Lorenzo
    Sculco, Thomas P.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2009, 467 (12) : 3283 - 3289